由初级保健药剂师进行的综合老年医疗评估
Kerry Wilbur1, Anuoluwapo F Awotunde1, Jennifer Bolt1,2,3
1Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.
概括
药剂师可以通过使用实用工具来加强老年护理,以进行超出药物审查的综合老年评估 (CGA). 这项研究确定了适用于社区和初级保健机构的基于证据的评估工具.
科学领域:
- 老年学是指老年学的学科.
- 主要护理医学 医疗保健
- 制药科学 制药科学
背景情况:
- 跨专业的合作对于优化老年人护理至关重要.
- 综合老年评估 (CGA) 在初级保健中具有挑战性,因为基于团队的基础设施有限.
- 药剂师是可访问的,并具有纵向的患者关系,使他们能够支持CGA.
研究的目的:
- 为药剂师确定实用,基于证据的工具,以进行全面的老年病学评估 (CGA).
- 评估药剂师领导的CGA领域,包括功能能力,移动性,认知和社会支持.
- 探索患者和专业人士对老年护理工具的看法.
主要方法:
- 一个经过修改的Delphi流程,涉及多学科小组,包括患者合作伙伴.
- 工具以七分级评分的重要性,共识定义为≥75%的同意.
- 分析的重点是工具的简洁性,响应选项和与患者偏好的调整.
主要成果:
- 评分很高的工具是简洁的,有细微的响应选择,适合药剂师领导的CGA.
- 患者合作伙伴的偏好与卫生专业人员的评级保持一致,强调个性化.
- 在初级保健机构内确定了转诊和随访的障碍.
结论:
- 药剂师可以使用已识别的工具有效地为综合老年病评估 (CGA) 作出贡献.
- 需要可访问,多学科的途径来将药剂师领导的CGA整合到初级保健中.
- 这些发现为药剂师提供了可行的机会,以改善老年护理的结果.
相关概念视频
01:15Drug Dosing: Geriatric Patients
215
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
215
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
221
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
221
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
213
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
213
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
188
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
188
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
226
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
226